Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction

被引:1366
作者
Luo, Ji [1 ]
Solimini, Nicole L. [1 ]
Elledge, Stephen J. [1 ]
机构
[1] Harvard Univ, Sch Med, Brigham & Womens Hosp, Howard Hughes Med Inst,Dept Med,Div Genet,Dept Ge, Boston, MA 02115 USA
关键词
DNA-DAMAGE RESPONSE; GROWTH-FACTOR RECEPTOR; HUMAN BREAST; NEOPLASTIC PHENOTYPE; GENOMIC INSTABILITY; SIGNALING PATHWAYS; MITOTIC CHECKPOINT; INDUCED SENESCENCE; RNA INTERFERENCE; P53; RESTORATION;
D O I
10.1016/j.cell.2009.02.024
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cancer is a complex collection of distinct genetic diseases united by common hallmarks. Here, we expand upon the classic hallmarks to include the stress phenotypes of tumorigenesis. We describe a conceptual framework of how oncogene and non-oncogene addictions contribute to these hallmarks and how they can be exploited through stress sensitization and stress overload to selectively kill cancer cells. In particular, we present evidence for a large class of non-oncogenes that are essential for cancer cell survival and present attractive drug targets. Finally, we discuss the path ahead to therapeutic discovery and provide theoretical considerations for combining orthogonal cancer therapies.
引用
收藏
页码:823 / 837
页数:15
相关论文
共 124 条
[61]   Targeting cyclins and cyclin-dependent kinases in cancer - Lessons from mice, hopes for therapeutic applications in human [J].
Lee, Young-Mi ;
Sicinski, Piotr .
CELL CYCLE, 2006, 5 (18) :2110-2114
[62]   5-Fluorouracil: Mechanisms of action and clinical strategies [J].
Longley, DB ;
Harkin, DP ;
Johnston, PG .
NATURE REVIEWS CANCER, 2003, 3 (05) :330-338
[63]  
MACDONALD C, 2005, NATURE, V438, P820
[64]   Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity [J].
Maira, Sauveur-Michel ;
Stauffer, Frederic ;
Brueggen, Josef ;
Furet, Pascal ;
Schnell, Christian ;
Fritsch, Christine ;
Brachmann, Saskia ;
Chene, Patrick ;
De Pover, Alain ;
Schoemaker, Kevin ;
Fabbro, Doriano ;
Gabriel, Daniela ;
Simonen, Marjo ;
Murphy, Leon ;
Finan, Peter ;
Sellers, William ;
Garcia-Echeverria, Carlos .
MOLECULAR CANCER THERAPEUTICS, 2008, 7 (07) :1851-1863
[65]   Modeling the therapeutic efficacy of p53 restoration in tumors [J].
Martins, Carla P. ;
Brown-Swigart, Lamorna ;
Evan, Gerard I. .
CELL, 2006, 127 (07) :1323-1334
[66]   Connecting chromosomes, crisis, and cancer [J].
Maser, RS ;
DePinho, RA .
SCIENCE, 2002, 297 (5581) :565-569
[67]   Autophagy suppresses tumor progression by limiting chromosomal instability [J].
Mathew, Robin ;
Kongara, Sameera ;
Beaudoin, Brian ;
Karp, Cristina M. ;
Bray, Kevin ;
Degenhardt, Kurt ;
Chen, Guanghua ;
Jin, Shengkan ;
White, Eileen .
GENES & DEVELOPMENT, 2007, 21 (11) :1367-1381
[68]   Anticancer antifolates: Current status and future directions. [J].
McGuire, JJ .
CURRENT PHARMACEUTICAL DESIGN, 2003, 9 (31) :2593-2613
[69]   Bcl-2-Targeted Antisense Therapy (Oblimersen Sodium): Towards Clinical Reality [J].
Moreira, Joao Nuno ;
Santos, Adriana ;
Simoes, Sergio .
REVIEWS ON RECENT CLINICAL TRIALS, 2006, 1 (03) :217-235
[70]   Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma [J].
Motzer, RJ ;
Michaelson, MD ;
Redman, BG ;
Hudes, GR ;
Wilding, G ;
Figlin, RA ;
Ginsberg, MS ;
Kim, ST ;
Baum, CM ;
DePrimo, SE ;
Li, JZ ;
Bello, CL ;
Theuer, CP ;
George, DJ ;
Rini, BI .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (01) :16-24